Etopozyd – frakcja wdychalna : dokumentacja proponowanych dopuszczalnych wielkości narażenia zawodowego

S. M. Sieber, J. Whang-Peng, C. Botkin, T. Knutsen, Teratogenic and cytogenetic effects of some plant-derived antitumor agents (vincristine, colchicine, maytansine, VP-16-213 and VM-26) in mice Teratology. ,vol. 18, pp. 31- 47 ,(1978) , 10.1002/TERA.1420180107

Tomasz Skorski, Michal O Nowicki, Rafal Falinski, Mateusz Koptyra, Artur Slupianek, Tomasz Stoklosa, Ewa Gloc, Margaret Nieborowska-Skorska, Janusz Blasiak, None, BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks Blood. ,vol. 104, pp. 3746- 3753 ,(2004) , 10.1182/BLOOD-2004-05-1941

Norimitsu TAKAHASHI, Shuichi KAI, Hisashi KOHMURA, Katsumi ISHIKAWA, Kohji KUROYANAGI, Yoshinori HAMAJIMA, Satoshi OHTA, Toshihito KADOTA, Shigeo KAWANO, Keiko OHTA, [Reproduction studies of VP 16-213 (VI)--Intravenous administration to rats during the perinatal and lactation periods]. Journal of Toxicological Sciences. ,vol. 11, pp. 281- 300 ,(1986) , 10.2131/JTS.11.SUPPLEMENTI_241

Maurice L. Slevin, The clinical pharmacology of etoposide Cancer. ,vol. 67, pp. 319- 329 ,(1991) , 10.1002/1097-0142(19910101)67:1+<319::AID-CNCR2820671319>3.0.CO;2-D

Johannes M.S. van Maanen, M.Vincent M. Lafleur, Dennis R.A. Mans, Eric van den Akker, Cor de Ruiter, Peter R. Kootstra, David Pappie, John de Vries, Jan Retèl, Herbert M. Pinedo, Effects of the ortho-quinone and catechol of the antitumor drug VP-16-213 on the biological activity of single-stranded and double-stranded ΦX174 DNA Biochemical Pharmacology. ,vol. 37, pp. 3579- 3589 ,(1988) , 10.1016/0006-2952(88)90388-7

B. Kalyanaraman, J. Nemec, Birandra K. Sinha, Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR Study. Biochemistry. ,vol. 28, pp. 4839- 4846 ,(1989) , 10.1021/BI00437A048

Christopher P. Murphy, Elizabeth A. Harden, Roger H. Herzig, Dose-related cutaneous toxicities with etoposide Cancer. ,vol. 71, pp. 3153- 3155 ,(1993) , 10.1002/1097-0142(19930515)71:10<3153::AID-CNCR2820711042>3.0.CO;2-#

Joost J.M Holthuis, Pieter E Postmus, Willem J Van Oort, Bram Hulshoff, Harriët Verleun, Dirk Th Sleijfer, Nanno H Mulder, PHARMACOKINETICS OF HIGH-DOSE ETOPOSIDE (VP 16-213) European Journal of Cancer and Clinical Oncology. ,vol. 22, pp. 1149- 1155 ,(1986) , 10.1016/0277-5379(86)90315-9

M Yagita, Y Ieki, R Onishi, C L Huang, M Adachi, S Horiike, Y Konaka, T Taki, M Miyake, Therapy-related leukemia and myelodysplasia following oral administration of etoposide for recurrent breast cancer. International Journal of Oncology. ,vol. 13, pp. 91- 96 ,(1998) , 10.3892/IJO.13.1.91

Laurent Nguyen, Etienne Chatelut, Christine Chevreau, Brigitte Tranchand, Isabelle Lochon, Jean-Marc Bachaud, Andr&#x000E9; Pujol, Georges Houin, Roland Bugat, Pierre Canal, Population pharmacokinetics of total and unbound etoposide. Cancer Chemotherapy and Pharmacology. ,vol. 41, pp. 125- 132 ,(1997) , 10.1007/S002800050718